Literature DB >> 23272667

Breathlessness and skeletal muscle weakness in patients undergoing lung health screening in primary care.

Julia L Kelly1, Sarah L Elkin, Jonathan Fluxman, Michael I Polkey, Michael A Soljak, Nicholas S Hopkinson.   

Abstract

Earlier diagnosis of COPD is a major public health challenge as symptoms may be attributed to the normal consequences of aging. The optimum strategy for identifying patients with COPD remains to be determined. People aged 35 and over (n = 1896) on a GP practice register were randomised to either invitation or an opportunistic lung health check which included spirometry, quadriceps strength and MRC dyspnoea score. Then, 101 participants subsequently completed the General Practice Physical Activity Questionnaire. A total of 335 attended over a 15-week period; 156 were in the invitation group and 179 from the opportunist group. In 25 persons, spirometry was unsatisfactory or contraindicated. Spirometry was normal in 204(65.8%) and restrictive in 36(11.6%). 70(22.6%) had airflow obstruction, corresponding to Global Initiative for Chronic Lung Disease (GOLD) stages I-IV in 18(5.8%), 35(11.3%), 14(4.5%) and 3(1.0%), respectively. The opportunist group were significantly more likely to have airflow obstruction 30.1% vs 14.3% (p = 0.001). Breathlessness was reported commonly (40.5%) and quadriceps strength correlated significantly with MRC dyspnoea score independent of age, sex, pack-years smoked, fat-free mass and FEV(1) percent predicted. This relationship was also present in the subgroup of healthy participants (n = 143). 51.5% of participants screened were classified as "inactive" and this group were weaker and more breathless than those who were more active. Airflow obstruction was more common in those screened opportunistically. Breathlessness and inactivity are common in patients taking part in spirometry screening. Breathlessness is significantly associated with leg strength independent of spirometry and should be amenable to interventions to increase physical activity.

Entities:  

Mesh:

Year:  2012        PMID: 23272667     DOI: 10.3109/15412555.2012.727923

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  17 in total

1.  Significance of Patent Foramen Ovale in Patients with GOLD Stage II Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Dario Martolini; Rebecca Tanner; Claire Davey; Mehul S Patel; Davide Elia; Helen Purcell; Paolo Palange; Nicholas S Hopkinson; Michael I Polkey
Journal:  Chronic Obstr Pulm Dis       Date:  2014-09-25

Review 2.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

Review 3.  Structural alterations of skeletal muscle in copd.

Authors:  Sunita Mathur; Dina Brooks; Celso R F Carvalho
Journal:  Front Physiol       Date:  2014-03-19       Impact factor: 4.566

4.  Breathlessness, physical activity and sustainability of healthcare.

Authors:  Amina Aitsi-Selmi; Nicholas S Hopkinson
Journal:  Eur Respir J       Date:  2015-01       Impact factor: 16.671

5.  Pedometers to enhance physical activity in COPD: a randomised controlled trial.

Authors:  Laura Mendoza; Paula Horta; José Espinoza; Miguel Aguilera; Nicolás Balmaceda; Ariel Castro; Mauricio Ruiz; Orlando Díaz; Nicholas S Hopkinson
Journal:  Eur Respir J       Date:  2014-09-26       Impact factor: 16.671

6.  Increased skeletal muscle-specific microRNA in the blood of patients with COPD.

Authors:  Anna Donaldson; Samantha A Natanek; Amy Lewis; William D-C Man; Nicholas S Hopkinson; Michael I Polkey; Paul R Kemp
Journal:  Thorax       Date:  2013-06-28       Impact factor: 9.139

7.  Lung function indices for predicting mortality in COPD.

Authors:  Afroditi K Boutou; Dinesh Shrikrishna; Rebecca J Tanner; Cayley Smith; Julia L Kelly; Simon P Ward; Michael I Polkey; Nicholas S Hopkinson
Journal:  Eur Respir J       Date:  2013-01-24       Impact factor: 16.671

8.  TargetCOPD: a pragmatic randomised controlled trial of targeted case finding for COPD versus routine practice in primary care: protocol.

Authors:  Rachel E Jordan; Peymané Adab; Sue Jowett; Jen L Marsh; Richard D Riley; Alexandra Enocson; Martin R Miller; Brendan G Cooper; Alice M Turner; Jon G Ayres; Kar Keung Cheng; Kate Jolly; Robert A Stockley; Sheila Greenfield; Stanley Siebert; Amanda Daley; David A Fitzmaurice
Journal:  BMC Pulm Med       Date:  2014-10-04       Impact factor: 3.317

9.  Skeletal muscle adiposity is associated with physical activity, exercise capacity and fibre shift in COPD.

Authors:  Matthew Maddocks; Dinesh Shrikrishna; Simone Vitoriano; Samantha A Natanek; Rebecca J Tanner; Nicholas Hart; Paul R Kemp; John Moxham; Michael I Polkey; Nicholas S Hopkinson
Journal:  Eur Respir J       Date:  2014-07-03       Impact factor: 16.671

10.  A retrospective study of two populations to test a simple rule for spirometry.

Authors:  Jill A Ohar; Barbara P Yawn; Gregg L Ruppel; James F Donohue
Journal:  BMC Fam Pract       Date:  2016-06-04       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.